Dronedarone: Clinical Trials

33 trials of Dronedarone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 7 unknown, 6 terminated, 1 active not recruiting. 11 Phase 4, 9 Not applicable, 9 Phase 3, 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 411Completed 4, Terminated 4, Unknown 2, Not yet recruiting 1
Not applicable9Completed 4, Unknown 4, Active not recruiting 1
Phase 39Completed 6, Terminated 2, Unknown 1
Phase 23Completed 2, Unknown 1
Phase 11Completed 1

Follow Dronedarone: new trials by email Literature Review of Dronedarone trials Research Report on Dronedarone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dronedarone Rhythm Intervention for Early Atrial Fibrillation
Dronedarone, flecainide, propafenone - Atrial Fibrillation (AF)
Phase 4Not yet recruitingInha University Hospital18982026-01-012025-12-22
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone - Persistent Atrial Fibrillation
Not applicableActive not recruitingBoston Scientific Corporation4842023-12-282026-08-28
Bioequivalence Study of Dronedarone Hydrochloride Tablets in Healthy Subjects Under Fasting Conditions
Dronedarone Hydrochloride Tablets, MULTAQ® (Dronedarone Hydrochloride Tablets) - Atrial Fibrillation (AF)
Not applicableCompletedShandong New Time Pharmaceutical Co., LTD512023-06-052026-02-09
Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation
Dronedarone, Placebo - Atrial Fibrillation
Phase 4UnknownShanghai East Hospital2682023-03-292023-04-13
Bioequivalence Study of Dronedarone Hydrochloride Tablets
Dronedarone Hydrochloride Tablets, MULTAQ® (Dronedarone Hydrochloride Tablets) - Atrial Fibrillation (AF)
Not applicableCompletedShandong New Time Pharmaceutical Co., LTD482022-11-142026-02-09
Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
Dronedarone - Atrial Fibrillation
Phase 4CompletedAmerican Heart Association3392021-10-292025-01-28
Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation
Antiarrhythmic drug including Propafenone, Sotalol, Dronedarone and Amiodarone, cryoballoon ablation - Atrial Fibrillation, Persistent, Arrhythmias, Cardiac
Not applicableCompletedRuijin Hospital3202021-10-012026-08-18
Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation
dronedarone, sotalol - Atrial Fibrillation
CompletedSanofi878102021-09-242024-01-09
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
dronedarone 400 mg Oral Tablet, Placebo - Atrial Fibrillation, Atrial Fibrillation Recurrent
Phase 4TerminatedTulane University School of Medicine222021-05-152025-10-30
Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG
Dronedarone, Amiodarone, Colchicine - Postoperative Atrial Fibrillation
Phase 2 / Phase 3Unknowndoaa rashwan482019-04-032019-04-05
Early Aggressive Invasive Intervention for Atrial Fibrillation
Cryoballoon-based PVI, Anti-Arrhythmic Drug Therapy - Atrial Fibrillation
Not applicableUnknownJason Andrade3032017-01-012022-10-10
Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
Ranolazine, Dronedarone, Ranolazine placebo - Atrial Fibrillation
Phase 2CompletedGilead Sciences1342012-01-242020-11-06
Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks
Dronedarone arm, Dronedarone - ICD, ICD SHOCKS
Not applicableUnknownRabin Medical Center202011-10-012011-09-08
Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
Propafenone, Dronedarone - Atrial Fibrillation
Not applicableCompletedSamsung Medical Center982011-05-012013-11-25
Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm
amiodarone, Dronedarone - Atrial Fibrillation
Not applicableUnknownEastbourne General Hospital1002011-03-012010-12-24
Drug Interaction Study With Dabigatran Etexilate and Dronedarone in Healthy Subjects
Dabigatran etexilate plus dronedarone, Dabigatran etexilate - Healthy
Phase 1CompletedBoehringer Ingelheim362011-02-012014-06-06
SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI
dronedarone, Placebo - Atrial Fibrillation
Phase 3CompletedUniversity of Utah332010-11-012016-02-19
Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation
Dronedarone - Atrial Fibrillation
Phase 4CompletedSanofi1542010-10-012013-06-07
Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement
Dronedarone, Placebo (for Dronedarone) - Atrial Fibrillation
Phase 4TerminatedSanofi762010-09-012013-02-12
Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial Fibrillation
DRONEDARONE (SR33589), placebo - Atrial Fibrillation
Phase 2CompletedSanofi1812010-09-012013-10-16

Showing 20 of 33. Sign in to see all of them.

Conditions studied

Atrial Fibrillation (29)  ·  Arrhythmias, Cardiac (5)  ·  Atrial Flutter (3)  ·  Heart Diseases (3)  ·  Cardiovascular Diseases (1)  ·  Heart Failure (1)  ·  Heart Murmurs (1)

Sponsors

Sanofi (15)  ·  Eastbourne General Hospital (2)  ·  Shandong New Time Pharmaceutical Co., LTD (2)  ·  American Heart Association (1)  ·  Boehringer Ingelheim (1)  ·  Boston Scientific Corporation (1)  ·  Gilead Sciences (1)  ·  Inha University Hospital (1)  ·  Jason Andrade (1)  ·  Rabin Medical Center (1)  ·  Ruijin Hospital (1)  ·  Samsung Medical Center (1)  ·  Shanghai East Hospital (1)  ·  Tulane University School of Medicine (1)  ·  University of Utah (1)

Countries

United States (10)  ·  Germany (9)  ·  Netherlands (9)  ·  Canada (8)  ·  France (8)  ·  Italy (8)  ·  Poland (7)  ·  Spain (7)  ·  United Kingdom (7)  ·  Australia (6)  ·  Belgium (6)  ·  China (6)  ·  Czechia (6)  ·  South Korea (6)  ·  Sweden (6)

Top investigators

Nassir F Marrouche, MD (2)  ·  A N Sulke, MD (1)  ·  Jason Andrade, M.D. (1)  ·  Jonathan P Piccini, MD, MHS (1)  ·  Li-qun Wu, MD,PhD (1)  ·  Oussama Wazni, M.D. (1)

Results publications

PMID 35717354, PMID 17804843, PMID 32500725, PMID 17804851, PMID 18565860, PMID 18760136, PMID 19213680, PMID 20384650, PMID 20436046, PMID 21296333, PMID 21576129, PMID 22082198, PMID 22770643, PMID 25134972, PMID 25378467, PMID 26226999, PMID 30342299, PMID 33197159, PMID 34664772, PMID 34958366, PMID 36342178, PMID 37018501, PMID 37025083, PMID 37155004, PMID 38007219, PMID 39423993, PMID 40295782, PMID 41865291, PMID 42041224, PMID 42677894, PMID 42774368

NIH funding

2009 (2), 2008 (1)